Author: "G. DeMicheli" / Topic: erythropoietin - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"G. DeMicheli"' showing total 4 results

Start Over Author "G. DeMicheli" Topic erythropoietin

Author: Montalcini G, Imarisio P, Bongiorno P, Biamino E, Caligaris F, and Demicheli G
Subjects: Adult, Aged, Humans, Iron Deficiencies, Middle Aged, Retrospective Studies, Erythropoietin adverse effects, Iron therapeutic use, Renal Dialysis
Abstract: The use of erythropoietin in dialysed patients leads to the gradual depletion of the body's iron reserves. It is important to assay iron blood levels in both patients receiving Epo therapy and those undergoing dialysis without this treatment. The most common method used is to assay ferritinemia, transferrinemia and the transferrin saturation levels. Using a retrospective study it was found that there is no significant difference in the request for iron supplementation in patients receiving Epo treatment compared to a control group not treated with Epo.
Published: 1996

Author: Imarisio P, Biamino E, Bongiorno P, Caligaris F, Demicheli G, Montalcini G, and Arnaud A
Subjects: Adult, Aged, Aged, 80 and over, Anemia blood, Anemia etiology, Erythrocyte Indices, Erythropoietin adverse effects, Hematocrit, Humans, Hypertension chemically induced, Immunologic Factors adverse effects, Italy, Kidney Failure, Chronic complications, Kidney Failure, Chronic therapy, Middle Aged, Recombinant Fusion Proteins adverse effects, Recombinant Fusion Proteins therapeutic use, Renal Dialysis, Anemia therapy, Erythropoietin therapeutic use, Immunologic Factors therapeutic use
Abstract: The paper reports a study carried out in the Dialysis Centres of Piedmont and the Aosta Valley on the use of erythropoietin in the treatment of anemia in patients undergoing regular dialysis. The efficacy of the drug and collateral and/or undesirable effects were evaluated. It was found that the drug was efficacious in 99.2% of the 342 patients receiving treatment on 30-6-1990, whereas undesirable effects were observed in 14.6% of cases. Data from the Nephrology and Dialysis Service in Asti are also reported.
Published: 1991

Author: G, Montalcini, P, Imarisio, P, Bongiorno, E, Biamino, F, Caligaris, and G, Demicheli
Subjects: Adult, Renal Dialysis, Iron, Humans, Iron Deficiencies, Middle Aged, Erythropoietin, Aged, Retrospective Studies
Abstract: The use of erythropoietin in dialysed patients leads to the gradual depletion of the body's iron reserves. It is important to assay iron blood levels in both patients receiving Epo therapy and those undergoing dialysis without this treatment. The most common method used is to assay ferritinemia, transferrinemia and the transferrin saturation levels. Using a retrospective study it was found that there is no significant difference in the request for iron supplementation in patients receiving Epo treatment compared to a control group not treated with Epo.
Published: 1996

Author: P, Imarisio, E, Biamino, P, Bongiorno, F, Caligaris, G, Demicheli, G, Montalcini, and A, Arnaud
Subjects: Adult, Aged, 80 and over, Erythrocyte Indices, Recombinant Fusion Proteins, Anemia, Middle Aged, Hematocrit, Italy, Renal Dialysis, Hypertension, Humans, Immunologic Factors, Kidney Failure, Chronic, Erythropoietin, Aged
Abstract: The paper reports a study carried out in the Dialysis Centres of Piedmont and the Aosta Valley on the use of erythropoietin in the treatment of anemia in patients undergoing regular dialysis. The efficacy of the drug and collateral and/or undesirable effects were evaluated. It was found that the drug was efficacious in 99.2% of the 342 patients receiving treatment on 30-6-1990, whereas undesirable effects were observed in 14.6% of cases. Data from the Nephrology and Dialysis Service in Asti are also reported.
Published: 1991

Books, media, physical & digital resources

Searchworks